---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-031864"
form_type: "8-K/A"
ticker: "PLSH"
cik: "0001552189"
company_name: "PANACEA LIFE SCIENCES HOLDINGS, INC."
filed_at: "2021-12-17T23:59:59+00:00"
generated_at: "2026-06-28T00:06:13.486179+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Panacea Life Sciences 2020 revenue $9.0M, net loss $5.2M; auditor raises going concern

## Summary
- Revenue $9.0M in 2020 vs $2.2M in 2019; net loss $5.2M vs $2.8M.
- Cash dropped to $84K from $8.5M year-end 2019; total assets $31.4M, liabilities $24.7M.
- Auditor raises going concern due to recurring losses; company needs additional capital.
- Related party note payable $15.1M at Dec 2020; $1M additional financing received Nov 2021.
- Marketable securities (XXII shares) valued at $2.85M; unrealized gain $1.43M in 2020.

## SEC filing metadata
- accession: 0001493152-21-031864
- form_type: 8-K/A
- ticker: PLSH
- cik: 0001552189
- company_name: PANACEA LIFE SCIENCES HOLDINGS, INC.
- filed_at: 2021-12-17T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1552189/000149315221031864/0001493152-21-031864-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1552189/000149315221031864/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-031864
- JSON: https://secwatch.observer/filing/0001493152-21-031864.json
- Plain text: https://secwatch.observer/filing/0001493152-21-031864.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.